aluates Reports

$ 0.0

Automative

RNAi Technologies - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-19Q7054

Global RNAi Technologies Market Insights and Forecast to 2028

BUY CHAPTERS

RNAi Technologies - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-19Q7054

Report

September 2024

Pages:89

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Alnylam Pharmaceuticals

Benitec Biopharma Ltd

Filmtec Corporation

Ionis Pharmaceuticals

Quark Pharmaceuticals Inc

RXi Pharmaceuticals

Qiagen NV

Invitrogen

Ambion

RNAi Technologies - Market Size

The global market for RNAi Technologies was estimated to be worth US$ 301.3 million in 2023 and is forecast to a readjusted size of US$ 430.3 million by 2030 with a CAGR of 4.8% during the forecast period 2024-2030

RNAi Technologies - Market

RNAi (Ribonucleic Acid Interference) a system in live cells to keep a check on the active genes is the next promising technology in the field of biotechnology. The major classes of RNAi are micro RNA and small interfering RNA. RNAi is said to be the replacement technology for the existing recombinant technology in the field of drug discovery and therapeutics.

North American market for RNAi Technologies was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for RNAi Technologies was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for RNAi Technologies was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of RNAi Technologies include Alnylam Pharmaceuticals, Benitec Biopharma Ltd, Filmtec Corporation, Ionis Pharmaceuticals, Quark Pharmaceuticals Inc., RXI Pharmaceuticals, Qiagen, Invitrogen and Ambion, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for RNAi Technologies, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of RNAi Technologies by region & country, by Type, and by Application.

The RNAi Technologies market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNAi Technologies.

Market Segmentation

Scope of RNAi Technologies - Market Report

Report Metric	Details
Report Name	RNAi Technologies - Market
Forecasted market size in 2030	US$ 430.3 million
CAGR	4.8%
Forecasted years	2024 - 2030
Segment by Type:	Oncology Ocular Disorders Respiratory Disorders Liver Diseases Other
Segment by Application	Research Therapeutics
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Alnylam Pharmaceuticals, Benitec Biopharma Ltd, Filmtec Corporation, Ionis Pharmaceuticals, Quark Pharmaceuticals Inc., RXI Pharmaceuticals, Qiagen, Invitrogen, Ambion
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of RNAi Technologies manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of RNAi Technologies in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of RNAi Technologies in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the RNAi Technologies - Market size in 2030?

Ans: The RNAi Technologies - Market size in 2030 will be US$ 430.3 million.

Who are the main players in the RNAi Technologies - Market report?

Ans: The main players in the RNAi Technologies - Market are Alnylam Pharmaceuticals, Benitec Biopharma Ltd, Filmtec Corporation, Ionis Pharmaceuticals, Quark Pharmaceuticals Inc., RXI Pharmaceuticals, Qiagen, Invitrogen, Ambion

What are the Application segmentation covered in the RNAi Technologies - Market report?

Ans: The Applications covered in the RNAi Technologies - Market report are Research, Therapeutics

What are the Type segmentation covered in the RNAi Technologies - Market report?

Ans: The Types covered in the RNAi Technologies - Market report are Oncology, Ocular Disorders, Respiratory Disorders, Liver Diseases, Other

Recommended Reports

Gene Therapy & RNAi

mRNA & Nucleic Acid

Cell & Gene Therapy

1 Market Overview

1.1 RNAi Technologies Product Introduction

1.2 Global RNAi Technologies Market Size Forecast

1.3 RNAi Technologies Market Trends & Drivers

1.3.1 RNAi Technologies Industry Trends

1.3.2 RNAi Technologies Market Drivers & Opportunity

1.3.3 RNAi Technologies Market Challenges

1.3.4 RNAi Technologies Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global RNAi Technologies Players Revenue Ranking (2023)

2.2 Global RNAi Technologies Revenue by Company (2019-2024)

2.3 Key Companies RNAi Technologies Manufacturing Base Distribution and Headquarters

2.4 Key Companies RNAi Technologies Product Offered

2.5 Key Companies Time to Begin Mass Production of RNAi Technologies

2.6 RNAi Technologies Market Competitive Analysis

2.6.1 RNAi Technologies Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by RNAi Technologies Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNAi Technologies as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Oncology

3.1.2 Ocular Disorders

3.1.3 Respiratory Disorders

3.1.4 Liver Diseases

3.1.5 Other

3.2 Global RNAi Technologies Sales Value by Type

3.2.1 Global RNAi Technologies Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global RNAi Technologies Sales Value, by Type (2019-2030)

3.2.3 Global RNAi Technologies Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Research

4.1.2 Therapeutics

4.2 Global RNAi Technologies Sales Value by Application

4.2.1 Global RNAi Technologies Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global RNAi Technologies Sales Value, by Application (2019-2030)

4.2.3 Global RNAi Technologies Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global RNAi Technologies Sales Value by Region

5.1.1 Global RNAi Technologies Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global RNAi Technologies Sales Value by Region (2019-2024)

5.1.3 Global RNAi Technologies Sales Value by Region (2025-2030)

5.1.4 Global RNAi Technologies Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America RNAi Technologies Sales Value, 2019-2030

5.2.2 North America RNAi Technologies Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe RNAi Technologies Sales Value, 2019-2030

5.3.2 Europe RNAi Technologies Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific RNAi Technologies Sales Value, 2019-2030

5.4.2 Asia Pacific RNAi Technologies Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America RNAi Technologies Sales Value, 2019-2030

5.5.2 South America RNAi Technologies Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa RNAi Technologies Sales Value, 2019-2030

5.6.2 Middle East & Africa RNAi Technologies Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions RNAi Technologies Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions RNAi Technologies Sales Value

6.3 United States

6.3.1 United States RNAi Technologies Sales Value, 2019-2030

6.3.2 United States RNAi Technologies Sales Value by Type (%), 2023 VS 2030

6.3.3 United States RNAi Technologies Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe RNAi Technologies Sales Value, 2019-2030

6.4.2 Europe RNAi Technologies Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe RNAi Technologies Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China RNAi Technologies Sales Value, 2019-2030

6.5.2 China RNAi Technologies Sales Value by Type (%), 2023 VS 2030

6.5.3 China RNAi Technologies Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan RNAi Technologies Sales Value, 2019-2030

6.6.2 Japan RNAi Technologies Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan RNAi Technologies Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea RNAi Technologies Sales Value, 2019-2030

6.7.2 South Korea RNAi Technologies Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea RNAi Technologies Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia RNAi Technologies Sales Value, 2019-2030

6.8.2 Southeast Asia RNAi Technologies Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia RNAi Technologies Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India RNAi Technologies Sales Value, 2019-2030

6.9.2 India RNAi Technologies Sales Value by Type (%), 2023 VS 2030

6.9.3 India RNAi Technologies Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Alnylam Pharmaceuticals

7.1.1 Alnylam Pharmaceuticals Profile

7.1.2 Alnylam Pharmaceuticals Main Business

7.1.3 Alnylam Pharmaceuticals RNAi Technologies Products, Services and Solutions

7.1.4 Alnylam Pharmaceuticals RNAi Technologies Revenue (US$ Million) & (2019-2024)

7.1.5 Alnylam Pharmaceuticals Recent Developments

7.2 Benitec Biopharma Ltd

7.2.1 Benitec Biopharma Ltd Profile

7.2.2 Benitec Biopharma Ltd Main Business

7.2.3 Benitec Biopharma Ltd RNAi Technologies Products, Services and Solutions

7.2.4 Benitec Biopharma Ltd RNAi Technologies Revenue (US$ Million) & (2019-2024)

7.2.5 Benitec Biopharma Ltd Recent Developments

7.3 Filmtec Corporation

7.3.1 Filmtec Corporation Profile

7.3.2 Filmtec Corporation Main Business

7.3.3 Filmtec Corporation RNAi Technologies Products, Services and Solutions

7.3.4 Filmtec Corporation RNAi Technologies Revenue (US$ Million) & (2019-2024)

7.3.5 Ionis Pharmaceuticals Recent Developments

7.4 Ionis Pharmaceuticals

7.4.1 Ionis Pharmaceuticals Profile

7.4.2 Ionis Pharmaceuticals Main Business

7.4.3 Ionis Pharmaceuticals RNAi Technologies Products, Services and Solutions

7.4.4 Ionis Pharmaceuticals RNAi Technologies Revenue (US$ Million) & (2019-2024)

7.4.5 Ionis Pharmaceuticals Recent Developments

7.5 Quark Pharmaceuticals Inc.

7.5.1 Quark Pharmaceuticals Inc. Profile

7.5.2 Quark Pharmaceuticals Inc. Main Business

7.5.3 Quark Pharmaceuticals Inc. RNAi Technologies Products, Services and Solutions

7.5.4 Quark Pharmaceuticals Inc. RNAi Technologies Revenue (US$ Million) & (2019-2024)

7.5.5 Quark Pharmaceuticals Inc. Recent Developments

7.6 RXI Pharmaceuticals

7.6.1 RXI Pharmaceuticals Profile

7.6.2 RXI Pharmaceuticals Main Business

7.6.3 RXI Pharmaceuticals RNAi Technologies Products, Services and Solutions

7.6.4 RXI Pharmaceuticals RNAi Technologies Revenue (US$ Million) & (2019-2024)

7.6.5 RXI Pharmaceuticals Recent Developments

7.7 Qiagen

7.7.1 Qiagen Profile

7.7.2 Qiagen Main Business

7.7.3 Qiagen RNAi Technologies Products, Services and Solutions

7.7.4 Qiagen RNAi Technologies Revenue (US$ Million) & (2019-2024)

7.7.5 Qiagen Recent Developments

7.8 Invitrogen

7.8.1 Invitrogen Profile

7.8.2 Invitrogen Main Business

7.8.3 Invitrogen RNAi Technologies Products, Services and Solutions

7.8.4 Invitrogen RNAi Technologies Revenue (US$ Million) & (2019-2024)

7.8.5 Invitrogen Recent Developments

7.9 Ambion

7.9.1 Ambion Profile

7.9.2 Ambion Main Business

7.9.3 Ambion RNAi Technologies Products, Services and Solutions

7.9.4 Ambion RNAi Technologies Revenue (US$ Million) & (2019-2024)

7.9.5 Ambion Recent Developments

8 Industry Chain Analysis

8.1 RNAi Technologies Industrial Chain

8.2 RNAi Technologies Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 RNAi Technologies Sales Model

8.5.2 Sales Channel

8.5.3 RNAi Technologies Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Alnylam Pharmaceuticals

Benitec Biopharma Ltd

Filmtec Corporation

Ionis Pharmaceuticals

Quark Pharmaceuticals Inc

RXi Pharmaceuticals

Qiagen NV

Invitrogen

Ambion

List of Tables

Table 1. RNAi Technologies Market Trends

Table 2. RNAi Technologies Market Drivers & Opportunity

Table 3. RNAi Technologies Market Challenges

Table 4. RNAi Technologies Market Restraints

Table 5. Global RNAi Technologies Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global RNAi Technologies Revenue Market Share by Company (2019-2024)

Table 7. Key Companies RNAi Technologies Manufacturing Base Distribution and Headquarters

Table 8. Key Companies RNAi Technologies Product Type

Table 9. Key Companies Time to Begin Mass Production of RNAi Technologies

Table 10. Global RNAi Technologies Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNAi Technologies as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global RNAi Technologies Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global RNAi Technologies Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global RNAi Technologies Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global RNAi Technologies Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global RNAi Technologies Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global RNAi Technologies Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global RNAi Technologies Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global RNAi Technologies Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global RNAi Technologies Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global RNAi Technologies Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global RNAi Technologies Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global RNAi Technologies Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global RNAi Technologies Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global RNAi Technologies Sales Value by Region (2019-2024) & (%)

Table 27. Global RNAi Technologies Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions RNAi Technologies Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions RNAi Technologies Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions RNAi Technologies Sales Value, (2025-2030) & (US$ Million)

Table 31. Alnylam Pharmaceuticals Basic Information List

Table 32. Alnylam Pharmaceuticals Description and Business Overview

Table 33. Alnylam Pharmaceuticals RNAi Technologies Products, Services and Solutions

Table 34. Revenue (US$ Million) in RNAi Technologies Business of Alnylam Pharmaceuticals (2019-2024)

Table 35. Alnylam Pharmaceuticals Recent Developments

Table 36. Benitec Biopharma Ltd Basic Information List

Table 37. Benitec Biopharma Ltd Description and Business Overview

Table 38. Benitec Biopharma Ltd RNAi Technologies Products, Services and Solutions

Table 39. Revenue (US$ Million) in RNAi Technologies Business of Benitec Biopharma Ltd (2019-2024)

Table 40. Benitec Biopharma Ltd Recent Developments

Table 41. Filmtec Corporation Basic Information List

Table 42. Filmtec Corporation Description and Business Overview

Table 43. Filmtec Corporation RNAi Technologies Products, Services and Solutions

Table 44. Revenue (US$ Million) in RNAi Technologies Business of Filmtec Corporation (2019-2024)

Table 45. Filmtec Corporation Recent Developments

Table 46. Ionis Pharmaceuticals Basic Information List

Table 47. Ionis Pharmaceuticals Description and Business Overview

Table 48. Ionis Pharmaceuticals RNAi Technologies Products, Services and Solutions

Table 49. Revenue (US$ Million) in RNAi Technologies Business of Ionis Pharmaceuticals (2019-2024)

Table 50. Ionis Pharmaceuticals Recent Developments

Table 51. Quark Pharmaceuticals Inc. Basic Information List

Table 52. Quark Pharmaceuticals Inc. Description and Business Overview

Table 53. Quark Pharmaceuticals Inc. RNAi Technologies Products, Services and Solutions

Table 54. Revenue (US$ Million) in RNAi Technologies Business of Quark Pharmaceuticals Inc. (2019-2024)

Table 55. Quark Pharmaceuticals Inc. Recent Developments

Table 56. RXI Pharmaceuticals Basic Information List

Table 57. RXI Pharmaceuticals Description and Business Overview

Table 58. RXI Pharmaceuticals RNAi Technologies Products, Services and Solutions

Table 59. Revenue (US$ Million) in RNAi Technologies Business of RXI Pharmaceuticals (2019-2024)

Table 60. RXI Pharmaceuticals Recent Developments

Table 61. Qiagen Basic Information List

Table 62. Qiagen Description and Business Overview

Table 63. Qiagen RNAi Technologies Products, Services and Solutions

Table 64. Revenue (US$ Million) in RNAi Technologies Business of Qiagen (2019-2024)

Table 65. Qiagen Recent Developments

Table 66. Invitrogen Basic Information List

Table 67. Invitrogen Description and Business Overview

Table 68. Invitrogen RNAi Technologies Products, Services and Solutions

Table 69. Revenue (US$ Million) in RNAi Technologies Business of Invitrogen (2019-2024)

Table 70. Invitrogen Recent Developments

Table 71. Ambion Basic Information List

Table 72. Ambion Description and Business Overview

Table 73. Ambion RNAi Technologies Products, Services and Solutions

Table 74. Revenue (US$ Million) in RNAi Technologies Business of Ambion (2019-2024)

Table 75. Ambion Recent Developments

Table 76. Key Raw Materials Lists

Table 77. Raw Materials Key Suppliers Lists

Table 78. RNAi Technologies Downstream Customers

Table 79. RNAi Technologies Distributors List

Table 80. Research Programs/Design for This Report

Table 81. Key Data Information from Secondary Sources

Table 82. Key Data Information from Primary Sources

Table 83. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. RNAi Technologies Product Picture

Figure 2. Global RNAi Technologies Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global RNAi Technologies Sales Value (2019-2030) & (US$ Million)

Figure 4. RNAi Technologies Report Years Considered

Figure 5. Global RNAi Technologies Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by RNAi Technologies Revenue in 2023

Figure 7. RNAi Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Oncology Picture

Figure 9. Ocular Disorders Picture

Figure 10. Respiratory Disorders Picture

Figure 11. Liver Diseases Picture

Figure 12. Other Picture

Figure 13. Global RNAi Technologies Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global RNAi Technologies Sales Value Market Share by Type, 2023 & 2030

Figure 15. Product Picture of Research

Figure 16. Product Picture of Therapeutics

Figure 17. Global RNAi Technologies Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 18. Global RNAi Technologies Sales Value Market Share by Application, 2023 & 2030

Figure 19. North America RNAi Technologies Sales Value (2019-2030) & (US$ Million)

Figure 20. North America RNAi Technologies Sales Value by Country (%), 2023 VS 2030

Figure 21. Europe RNAi Technologies Sales Value (2019-2030) & (US$ Million)

Figure 22. Europe RNAi Technologies Sales Value by Country (%), 2023 VS 2030

Figure 23. Asia Pacific RNAi Technologies Sales Value (2019-2030) & (US$ Million)

Figure 24. Asia Pacific RNAi Technologies Sales Value by Country (%), 2023 VS 2030

Figure 25. South America RNAi Technologies Sales Value (2019-2030) & (US$ Million)

Figure 26. South America RNAi Technologies Sales Value by Country (%), 2023 VS 2030

Figure 27. Middle East & Africa RNAi Technologies Sales Value (2019-2030) & (US$ Million)

Figure 28. Middle East & Africa RNAi Technologies Sales Value by Country (%), 2023 VS 2030

Figure 29. Key Countries/Regions RNAi Technologies Sales Value (%), (2019-2030)

Figure 30. United States RNAi Technologies Sales Value, (2019-2030) & (US$ Million)

Figure 31. United States RNAi Technologies Sales Value by Type (%), 2023 VS 2030

Figure 32. United States RNAi Technologies Sales Value by Application (%), 2023 VS 2030

Figure 33. Europe RNAi Technologies Sales Value, (2019-2030) & (US$ Million)

Figure 34. Europe RNAi Technologies Sales Value by Type (%), 2023 VS 2030

Figure 35. Europe RNAi Technologies Sales Value by Application (%), 2023 VS 2030

Figure 36. China RNAi Technologies Sales Value, (2019-2030) & (US$ Million)

Figure 37. China RNAi Technologies Sales Value by Type (%), 2023 VS 2030

Figure 38. China RNAi Technologies Sales Value by Application (%), 2023 VS 2030

Figure 39. Japan RNAi Technologies Sales Value, (2019-2030) & (US$ Million)

Figure 40. Japan RNAi Technologies Sales Value by Type (%), 2023 VS 2030

Figure 41. Japan RNAi Technologies Sales Value by Application (%), 2023 VS 2030

Figure 42. South Korea RNAi Technologies Sales Value, (2019-2030) & (US$ Million)

Figure 43. South Korea RNAi Technologies Sales Value by Type (%), 2023 VS 2030

Figure 44. South Korea RNAi Technologies Sales Value by Application (%), 2023 VS 2030

Figure 45. Southeast Asia RNAi Technologies Sales Value, (2019-2030) & (US$ Million)

Figure 46. Southeast Asia RNAi Technologies Sales Value by Type (%), 2023 VS 2030

Figure 47. Southeast Asia RNAi Technologies Sales Value by Application (%), 2023 VS 2030

Figure 48. India RNAi Technologies Sales Value, (2019-2030) & (US$ Million)

Figure 49. India RNAi Technologies Sales Value by Type (%), 2023 VS 2030

Figure 50. India RNAi Technologies Sales Value by Application (%), 2023 VS 2030

Figure 51. RNAi Technologies Industrial Chain

Figure 52. RNAi Technologies Manufacturing Cost Structure

Figure 53. Channels of Distribution (Direct Sales, and Distribution)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

RNAi Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antisense and RNAi Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global RNAi for Therapeutic Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

RNAi Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global RNA Interference Technology Market Research Report 2025

Global RNAi Therapeutics Market Research Report 2024

Antisense and RNAi Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Small Interfering RNA siRNA based Therapeutics Market Research Report 2024

Global RNA Vaccines Market Insights Forecast to 2030

Global Small Interfering RNA siRNA Drugs Market Research Report 2024

Global Vector Based RNAi Market Research Report 2024

Global RNA Interference RNAi Based Therapeutics Market Research Report 2024

Global RNA Therapeutics Market Research Report 2024

Transfection Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global RNA Sequencing Technologies Market Insights Forecast to 2030

Transcriptome Technology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global RNAi based Biopesticides Market Research Report 2024

Global RNAi Biopesticides Market Research Report 2024

Global Gene Interference Service Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions